Why Are Analysts So Bullish On This Tumbling Biotech Company?
February 08, 2016 at 10:32 AM EST
In the past month, shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have plummeted more than 45 percent. Granted that the biotech ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.